Olga Venditti

1.3k total citations
26 papers, 786 citations indexed

About

Olga Venditti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Olga Venditti has authored 26 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Olga Venditti's work include Colorectal Cancer Treatments and Studies (8 papers), Bone health and treatments (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Olga Venditti is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Bone health and treatments (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Olga Venditti collaborates with scholars based in Italy, United States and Netherlands. Olga Venditti's co-authors include Bruno Vincenzi, Daniele Santini, Giuseppe Tonini, Sara Galluzzo, Anna Maria Frezza, Gaia Schiavon, Michele Caraglia, Francesco Pantano, Antonio Russo and Alice Zoccoli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Olga Venditti

23 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Venditti Italy 8 517 204 153 151 117 26 786
Nikki Knijn Netherlands 13 734 1.4× 224 1.1× 73 0.5× 143 0.9× 132 1.1× 19 879
Shozo Mori Japan 11 288 0.6× 201 1.0× 138 0.9× 139 0.9× 69 0.6× 63 688
Dulabh Monga United States 15 539 1.0× 227 1.1× 396 2.6× 158 1.0× 119 1.0× 74 1.1k
A. M. M. Eggermont Netherlands 11 549 1.1× 212 1.0× 234 1.5× 169 1.1× 95 0.8× 25 919
Wolfgang M. Brueckl Germany 21 749 1.4× 496 2.4× 329 2.2× 58 0.4× 177 1.5× 60 1.2k
Regina Esser Germany 14 921 1.8× 472 2.3× 115 0.8× 200 1.3× 170 1.5× 39 1.1k
E. Joosens Belgium 11 258 0.5× 173 0.8× 133 0.9× 59 0.4× 72 0.6× 26 587
K. Park South Korea 13 664 1.3× 482 2.4× 196 1.3× 39 0.3× 98 0.8× 43 994
Masafumi Inokuchi Japan 16 241 0.5× 73 0.4× 178 1.2× 26 0.2× 210 1.8× 61 663
Chueh‐Chuan Yen Taiwan 19 386 0.7× 377 1.8× 203 1.3× 62 0.4× 73 0.6× 58 930

Countries citing papers authored by Olga Venditti

Since Specialization
Citations

This map shows the geographic impact of Olga Venditti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Venditti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Venditti more than expected).

Fields of papers citing papers by Olga Venditti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Venditti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Venditti. The network helps show where Olga Venditti may publish in the future.

Co-authorship network of co-authors of Olga Venditti

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Venditti. A scholar is included among the top collaborators of Olga Venditti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Venditti. Olga Venditti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cortellini, Alessio, Sebastiano Buti, Melissa Bersanelli, et al.. (2020). Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma. Current Urology. 14(2). 98–104. 5 indexed citations
2.
Cortellini, Alessio, Federico Bozzetti, Pierpaolo Palumbo, et al.. (2020). Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study. Scientific Reports. 10(1). 1456–1456. 68 indexed citations
3.
Parisi, Alessandro, Alessio Cortellini, Olga Venditti, et al.. (2020). Family History of Cancer as Potential Prognostic Factor in Stage III Colorectal Cancer: a Retrospective Monoinstitutional Study. Journal of Gastrointestinal Cancer. 51(3). 1094–1101. 2 indexed citations
4.
Cortellini, Alessio, Katia Cannita, Alessandro Parisi, et al.. (2019). <p>Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice</p>. OncoTargets and Therapy. Volume 12. 2159–2170. 5 indexed citations
5.
Cortellini, Alessio, Katia Cannita, Alessandro Parisi, et al.. (2019). Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation. Bioengineering. 6(1). 11–11. 2 indexed citations
6.
Cortellini, Alessio, Alessandro Parisi, Katia Cannita, et al.. (2018). Timed-flat infusion (TFI) 5-fluorouracil with irinotecan and oxaliplatin in pancreatic adenocarcinomas: A single institution experience with FIr/FOx regimen. Annals of Oncology. 29. v37–v38.
7.
Cortellini, Alessio, Alessandro Parisi, Olga Venditti, et al.. (2018). The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis‑generator’ study from clinical practice. Oncology Letters. 16(6). 7195–7203. 2 indexed citations
8.
Cortellini, Alessio, Katia Cannita, Alessandro Parisi, et al.. (2018). Timed‑flat infusion of 5‑fluorouracil with docetaxel and oxaliplatin as first‑line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen. Oncology Reports. 40(2). 803–812. 1 indexed citations
9.
Venditti, Olga, Delia De Lisi, Marco Caricato, et al.. (2015). Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis. BMC Cancer. 15(1). 87–87. 23 indexed citations
10.
Russano, Marco, Bruno Vincenzi, Olga Venditti, et al.. (2015). Pazopanib and pancreatic toxicity: a case report. BMC Research Notes. 8(1). 196–196. 7 indexed citations
11.
Annibali, Ombretta, Maria Teresa Petrucci, Daniele Santini, et al.. (2015). Alkaline Phosphatase (ALP) Levels in Multiple Myeloma (MM) And Cancer With Bone Lesions : Is There any Difference?. Clinical Lymphoma Myeloma & Leukemia. 15. e125–e125. 3 indexed citations
12.
Santini, Daniele, Bruno Vincenzi, Olga Venditti, et al.. (2013). Sunitinib in Malignant Melanoma: A Treatment Option Only for KIT -Mutated Patients?. Future Oncology. 9(12). 1809–1811. 4 indexed citations
13.
Santini, Daniele, Gaetano Lanzetta, Emanuela Dell’Aquila, et al.. (2013). ‘Old' and ‘new' drugs for the treatment of cancer pain. Expert Opinion on Pharmacotherapy. 14(4). 425–433. 6 indexed citations
14.
Santini, Daniele, Bruno Vincenzi, Raffaele Addeo, et al.. (2012). Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?. Annals of Oncology. 23(9). 2313–2318. 149 indexed citations
15.
Santini, Daniele, Bruno Vincenzi, Francesco Maria Guida, et al.. (2012). Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study. The Lancet Oncology. 13(10). 1020–1024. 77 indexed citations
16.
Vincenzi, Bruno, Andrea Napolitano, Loretta D’Onofrio, et al.. (2011). Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside. Expert Opinion on Investigational Drugs. 20(12). 1685–1705. 4 indexed citations
17.
Vincenzi, Bruno, Alice Zoccoli, Francesco Pantano, Olga Venditti, & Sara Galluzzo. (2010). CETUXIMAB: From Bench to Bedside. Current Cancer Drug Targets. 10(1). 80–95. 100 indexed citations
18.
Vincenzi, Bruno, Daniele Santini, Antonio Russo, et al.. (2010). Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. The Oncologist. 15(1). 85–92. 138 indexed citations
19.
Vincenzi, Bruno, Daniele Santini, Antonio Russo, et al.. (2009). Bevacizumab in association with de Gramont 5‐fluorouracil/folinic acid in patients with oxaliplatin‐, irinotecan‐, and cetuximab‐refractory colorectal cancer. Cancer. 115(20). 4849–4856. 28 indexed citations
20.
Vincenzi, Bruno, Daniele Santini, Giuseppe Patti, et al.. (2007). Association of interleukin-1 gene polymorphisms with gastric cancer: A meta-analysis. Journal of Clinical Oncology. 25(18_suppl). 21142–21142. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nikki Knijn Breakdown of academic impact, for papers by Shozo Mori Breakdown of academic impact, for papers by Dulabh Monga Breakdown of academic impact, for papers by A. M. M. Eggermont Breakdown of academic impact, for papers by Wolfgang M. Brueckl Breakdown of academic impact, for papers by Regina Esser Breakdown of academic impact, for papers by E. Joosens Breakdown of academic impact, for papers by K. Park Breakdown of academic impact, for papers by Masafumi Inokuchi Breakdown of academic impact, for papers by Chueh‐Chuan Yen
Rankless by CCL
2026